Newborn Solutions, a CataloniaBio & HealthTech member, has closed a €600,000 round to carry out clinical validation of its first medical device Neosonics in 2021.
The two undisclosed investors that will be joining the medtech company’s shareholders are from the healthcare sector and will be able to commercialise the product in the future.
The innovation Neosonics will bring to the market is its non-invasive testing for meningitis in newborns.
Photo: Rita Quesada, Javier Jiménez, QuiqueBassat and Marta Príncep, executives at Newborn Solutions.
Want to know more about Newborn Solutions? We recommend this video of CataloniaBio & HealthTech interviewing them:
Comments